Articles

Dietitians delivered structured, individual-based lifestyle education for glycemic control in a primary care setting which resulted in….

The addition of glyburide as an oral medication may improve the outcome of gestational diabetes in women who struggle with insulin dosing….

A new literature review suggests that not all diabetic patients are at equal risk for coronary heart disease…. 

Obesity and hypertriglyceridemia are significant risk factors for diabetic neuropathy independent of glycemic control….

Understanding the role of p75NTR on glucose regulation in mice may lead to a potential therapy for insulin resistance and type 2 diabetes in humans….

A panel of FDA advisers has voted to ease restrictions on access to Avandia (rosiglitazone), a past blockbuster drug brought low by reports that it increased the risk of heart attacks….

Sucralose, the artificial sweetener of Splenda®, was found to have an effect on the absorption of glucose and subsequent insulin secretion in non-diabetic, obese individuals…. M. Yanina Pepino, PhD, and colleagues out of Washington University School of Medicine, St. Louis, began looking at non-nutritive sweeteners such as Splenda® (sucralose) and …

Scientists determine an immune protein, CD52, suppresses the autoimmune response against pancreatic beta cells….

Studies found that chlorogenic acid, commonly found in coffee, failed to improve metabolic parameters in obese mice….

University of Missouri researchers have used adult bone marrow stem cells along with a novel anti-inflammatory drug to cure type 1 diabetes in mice….